Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.
Journal: Cancer discovery
Published: December 31, 2025
Oncogene Mutations: The Shared Antigen Vaccines That Work?
Journal: Annual review of medicine
Published: December 05, 2025
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial.
Journal: Nature communications
Published: December 02, 2025
Clinical, genomic, and spatial transcriptomic features of pancreatic adenosquamous carcinoma support subtype-specific therapeutic strategies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 01, 2025
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.
Journal: Nature communications
Published: June 25, 2025
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.
Journal: Nature communications
Published: June 25, 2025
Dual checkpoint blockade for microsatellite instability-high colorectal cancer.
Journal: Lancet (London, England)
Published: January 18, 2025
Unlocking the promise of RAS inhibition in pancreatic cancer.
Journal: Nature reviews. Gastroenterology & hepatology
Published: June 14, 2024
Last Updated: 09/26/2026